So right now PLS market cap over 400% of AJM, yet has a planned production output of only 50% more.
The main difference IMO is that PLS has no offtake uncertainty, AJM does...hence the SP woes right now.
Good to remember however,
* PLS also is waiting on its ship (likely same ship as AJM). The announcement stated 'Cargoes will be shipped on “Handy” sized vessels of up to 40,000 tonnes'...so perhaps they are building up the stockpile at port. Additionally stated 'Altura’s appointed shipping agents have booked and are managing the Company’s maiden cargo.' Booked sounds very much like an agreement to take the first boatload is already agreed to.
* 2 weeks ago, AJM already had at least 4000 tonnes of 6%+ grade concentrate ready at Port for export. So the plant is running. Iron levels are fine, grade is in bonus payment range.
* Ramp up to 220kt by end of year is still the plan.
Never fun retracing this hard but I'm sticking to my plan. Still believe the company is worth 70c at 220kt/y production and near double that at stage 2 based upon the numbers.
- Forums
- ASX - By Stock
- 1MC
- News ramp up
News ramp up, page-56
-
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1MC (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.8¢ |
Change
-0.003(9.68%) |
Mkt cap ! $8.486M |
Open | High | Low | Value | Volume |
3.0¢ | 3.0¢ | 2.8¢ | $13.15K | 453.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 142985 | 2.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.0¢ | 361122 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 142985 | 0.028 |
1 | 35000 | 0.025 |
1 | 41708 | 0.023 |
1 | 61938 | 0.022 |
1 | 50000 | 0.021 |
Price($) | Vol. | No. |
---|---|---|
0.030 | 361122 | 7 |
0.031 | 523991 | 8 |
0.032 | 38813 | 2 |
0.033 | 8100 | 2 |
0.034 | 269773 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
1MC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online